Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02169284
Title Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
Lahey Hospital and Medical Center Burlington Massachusetts 01805 United States Details
University of Rochester Rochester New York 14642 United States Details
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 United States Details
Urology San Antonio Research PA San Antonio Texas 78229 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field